or Try an Advanced Search...

    Technical Analysis for KALA - Kala Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    C 6.43 -0.54% -0.04
    KALA closed down 0.54 percent on Wednesday, November 20, 2024, on 1.75 times normal volume. It was able to find support at its 50 day moving average. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical KALA trend table...
    Date Alert Name Type % Chg
    New Downtrend Bearish 0.00%
    50 DMA Support Bullish 0.00%
    Hammer Candlestick Bullish 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Fell Below 200 DMA Bearish -0.54%
    Older End-of-Day Signals for KALA ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Support about 16 hours ago
    Down 5% about 17 hours ago
    Fell Below 50 DMA about 17 hours ago
    Down 1 ATR about 17 hours ago
    1.5x Volume Pace about 18 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    KALA Chart by TradingView
    Basic chart:

    Profile

    Kala Pharmaceuticals Inc. is a United States-based company that is developing ophthalmic treatments based on the Company’s Mucosal Penetrating Product (MPP) platform. The Company’s topical ocular MPP formulations enhance penetration of diverse therapeutic agents into ocular tissue, including those in the back of the eye, by facilitating penetration through the mucus layer of tear film. Its product development pipeline includes a 1% formulation of loteprednol etabonate to treat post-surgical ocular inflammation and pain; a 0.25% LE-MPP formulation for dry eye, blepharitis, and retinal disease, and a topically applied receptor tyrosine kinase inhibitir (RTKi-MPP) for the treatment of wet age-related macular degeneration (AMD).
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Pain Organ Systems Eye Inflammation Ophthalmic Macular Degeneration Tyrosine Kinase Retina Wet Age Related Macular Degeneration Glucocorticoids Receptor Tyrosine Kinase Retinal Disease Blepharitis Post Surgical Ocular Inflammation

    Is KALA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 KALA BIO GAAP EPS of -$1.93 beats by $0.50
    Nov 12 KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update
    Aug 8 KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
    Aug 6 KALA BIO GAAP EPS of -$3.16 beats by $1.25
    Aug 6 KALA BIO GAAP EPS of -$3.16
    Aug 6 KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update
    Jun 27 Kala Pharmaceuticals to sell 1.197M shares at $5.85 in private placement
    Jun 27 KALA BIO Announces $12,500,000 Private Placement
    May 29 KALA BIO to Present at Jefferies Global Healthcare Conference
    May 21 Wall Street Analysts Just Trimmed Price Target for KALA BIO, Inc. (NASDAQ:KALA)
    See more KALA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 10.97
    52 Week Low 4.21
    Average Volume 22,483
    200-Day Moving Average 6.59
    50-Day Moving Average 6.05
    20-Day Moving Average 6.90
    10-Day Moving Average 6.89
    Average True Range 0.39
    RSI (14) 47.64
    ADX 31.43
    +DI 20.72
    -DI 25.11
    Chandelier Exit (Long, 3 ATRs) 6.68
    Chandelier Exit (Short, 3 ATRs) 6.32
    Upper Bollinger Bands 7.50
    Lower Bollinger Band 6.30
    Percent B (%b) 0.11
    BandWidth 17.34
    MACD Line 0.17
    MACD Signal Line 0.28
    MACD Histogram -0.1148
    Fundamentals Value
    Market Cap 17.32 Million
    Num Shares 2.69 Million
    EPS -22.38
    Price-to-Earnings (P/E) Ratio -0.29
    Price-to-Sales 1.16
    Price-to-Book 1.77
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.18
    Resistance 3 (R3) 7.12 6.81 7.06
    Resistance 2 (R2) 6.81 6.62 6.84 7.01
    Resistance 1 (R1) 6.62 6.50 6.72 6.68 6.97
    Pivot Point 6.31 6.31 6.36 6.34 6.31
    Support 1 (S1) 6.12 6.12 6.22 6.18 5.89
    Support 2 (S2) 5.81 6.00 5.84 5.85
    Support 3 (S3) 5.62 5.81 5.81
    Support 4 (S4) 5.68